ATOSSA THERAPEUTICS, INC.: capex

Value{"amount": 14000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2023-01-01 – 2023-09-30
Statuscurrent
EntityATOSSA THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001437749-23-031424 · Open the official SEC filing →
Retrieved: 2026-08-19T14:48:04.568110+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001488039/capex/2023-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/e409d272-8fe3-43db-add2-fd33eab491bc

History

From the Record